At a glance
- Originator Eisai Co Ltd
- Class Amides; Antiepileptic drugs; Nitro compounds; Organic boron compounds; Pyridines
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 25 Sep 2022 Discontinued - Phase-I for Epilepsy (In the elderly, In volunteers, In adults) in Japan (PO) (Eisai Co Ltd pipeline, September 2022)
- 25 Sep 2022 Discontinued - Phase-I for Epilepsy (In the elderly, In volunteers, In adults) in Japan (PO) (Eisai Co Ltd pipeline, September 2022)
- 25 Sep 2022 Discontinued - Phase-II for Epilepsy in USA (PO) (Eisai Co Ltd pipeline, September 2022)